To Increase Patient Access

Post Archives

June 28, 2023
Non-English- Speaking Patients With Cancer Face Big Barriers to Care in the U.S., But Help Is Available

Patients who don't speak English face additional obstacles during their cancer journey but family, caregivers and the law are on their side.

Read More
June 22, 2023
2023 Hope Award Runner Up

Jennifer Ortiz Is the 1st runner-up recipient of the 2023 EBCI National HOPE Award.

Read More
June 8, 2023
How Kiyatec’s 3D Predict™ Directs Cancer Care

Thanks to Kiyatec’s 3D Predict, cancer patients with elevated HCG levels and their physicians are seeing game-changing results.

Read More
June 2, 2023
EBCI To Attend ASCO 2023

EBCI focuses on brain disease education, outreach, and awareness to this patient community and their families...worldwide.

Read More
June 1, 2023
Congratulations to Alyssa, the 2023 Hope Award Winner

Alyssa Gohra is the 2023 National Hope Award winner.

Read More
May 26, 2023
Nivolumab Clinical Trial

National Cancer Institute (NCI) researchers are conducting a study of patients with IDH-mutated gliomas.

Read More
May 19, 2023
2023 Hope Award Winner

The End Brain Cancer Initiative is pleased to announce that Alyssa Gohra is the 2023 National HOPE Award winner.

Read More
May 17, 2023
Imvax Immunotherapy Clinical Study

Imvax is conducting a new phase 2b clinical study, with a combination immunotherapy, for newly diagnosed patients with glioblastoma.

Read More
May 16, 2023
Building Resilience through Gratitude & Self Care

The Pacific Neuroscience Institute has created a series of videos featuring patients and caregivers discussing brain tumor treatments.

Read More
April 26, 2023
Submit Comments on use of Placebos in Clinical Trials

The FDA is drafting new guidance on the use of external data in lieu of placebos in clinical trials. Please support this change.

Read More
April 20, 2023
Nominations for the 2023 "National HOPE Award"

Each May the EndBrainCancer Initiative, in Partnership with Novocure, has presented the HOPE award to brain cancer patients who deeply inspire us with their courage and story.

Read More
April 13, 2023
Recruiting Now for Patients with Recurrent GBM

If you have been diagnosed with rGBM (first recurrence only), would you like to participate in a PAID short interview?

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram